Showing 1001-1010 of 1437 results for "".
- Introducing Juvéderm It, Allergan's Newest Ad Campaignhttps://modernaesthetics.com/news/introducing-juvderm-it-allergans-newest-ad-campaign/2472020/Allergan plc is rolling out a new Juvéderm advertising campaign that aims to make this family of fillers a household name. Comprising a modernized logo, a bright, poppy color scheme, an edgy soundtrack and robust social media component, Juvéderm It is the first new adv
- Cynosure's TempSure™ Envi Set to Debut at 2018 AAD Meetinghttps://modernaesthetics.com/news/cynosures-tempsure-envi-set-to-debut-at-2018-aad-meeting/2472144/Hologic's Cynosure division is launching TempSure™ Envi – an FDA-cleared advanced radiofrequency device. TempSure™ Envi heats the deep layers of skin to regenerate collagen and
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- NFL Analyst Deion Sanders Named New Brand Ambassador for Botox Cosmetichttps://modernaesthetics.com/news/nfl-analyst-deion-sanders-named-new-brand-ambassador-for-botox-cosmetic/2472201/NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan also released two vide
- Neothetics, Inc.'s Stock Tumbles Following "Unambiguous" Negative LIPO-202 Resultshttps://modernaesthetics.com/news/neothetics-incs-stock-tumbles-following-unambiguous-negative-lipo-202-results/2472217/Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-concept trial. Neothetics Inc. shares d
- Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studieshttps://modernaesthetics.com/news/restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit-in-phase-4-studies/2472251/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na
- Deadline Extended for Medical Spa State of the Industry Statistical Studyhttps://modernaesthetics.com/news/deadline-extended-for-medical-spa-state-of-the-industry-statistical-study/2472272/The American Med Spa Association (AmSpa) has extended the deadline for the 2017 Medical Spa St
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t